ctrl K

Price Alert

Rein Therapeutics Inc. (RNTX)

NASDAQ: RNTX · Real-Time Price · USD

1.16

0.00 (0.43%)

At close: Aug 15, 2025, 3:01 PM

Rein Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	12.87M	17.31M	5.19M	3.6M
Short-Term Investments	n/a	n/a	16.05M	42.33M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	2K	2.19M	24K	24K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	676K	746K	631K	25K
Total Current Assets	13.66M	18.27M	21.87M	48.18M
Property-Plant & Equipment	1K	19K	110K	280K
Goodwill & Intangibles	48.53M	85.53M	n/a	n/a
Total Long-Term Assets	48.53M	87.74M	134K	304K
Total Assets	62.19M	106.01M	22.01M	48.48M
Account Payables	911K	1.19M	1.72M	1.21M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	122K	206K	181K	60K
Total Current Liabilities	5.75M	4.38M	3.38M	4.51M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	277K	91.41M	n/a	n/a
Total Long-Term Liabilities	47.05M	94.74M	n/a	69K
Total Liabilities	7.8M	99.12M	3.38M	4.58M
Total Debt	n/a	48K	33K	162K
Common Stock	108K	91K	91K	91K
Retained Earnings	-351.4M	-288.52M	-272.79M	-245.46M
Comprehensive Income	-18K	-63K	-48K	-13K
Shareholders Equity	54.39M	6.89M	18.62M	43.9M
Total Investments	n/a	n/a	16.05M	42.33M